Disclosures - L. Sloan: Speaker's Bureau; Current; Abbott, AstraZeneca. Advisory Panel; Current; Corcept Therapeutics. Speaker's Bureau; Current; Corcept Therapeutics, Boehringer Ingelheim International GmbH, Bayer AG, Eli Lilly and Company, Lilly. Advisory Panel; Current; Idorsia Pharmaceuticals Ltd.. Speaker's Bureau; Current; Madrigal Pharmaceuticals, Inc.. Advisory Panel; Current; Novo Nordisk. Advisory Panel; Ended; Xeris Pharmaceuticals, Inc.. Speaker's Bureau; Ended; Xeris Pharmaceuticals, Inc. V. Aroda: Research Support; Current; Amgen Inc.. Research Support; Ended; Applied Therapeutics. Research Support; Current; AstraZeneca. Other - Biomea; institutional consultant and research support; Current; Biomea. Research Support; Current; Boehringer Ingelheim International GmbH, Corcept Therapeutics, Eli Lilly and Company, Fractyl Health, Inc., Novo Nordisk, Pfizer Inc.. Consultant; Current; Recordati S.p.A. Research Support; Current; Rhythm Pharmaceuticals, Inc.. Consultant; Ended; Servier Laboratories, Mediflix, Inc., Roche Pharmaceuticals, Sanofi. Other - spouse is an employee; Current; Flagship Pioneering. Other - spouse was an employee; Ended; AditumBio, Johnson & Johnson. R.S. Busch: Research Support; Current; Eli Lilly and Company, Novo Nordisk, Corcept Therapeutics. Speaker's Bureau; Current; Corcept Therapeutics, Bayer AG, Madrigal Pharmaceuticals, Inc., Ascendis Pharma A/S. Research Support; Current; AstraZeneca. J.B. Buse: Consultant; Current; Aardvark Therapeutics, Altimmune, Alveus Therapeutics, Amgen Inc., Antag Therapeutics, Aqua Medical, AstraZeneca, Boehringer Ingelheim International GmbH. Other - Consultant and clinical trial support; Current; Corcept Therapeutics. Consultant; Ended; Dexcom, Inc.. Consultant; Current; Eli Lilly and Company. Consultant; Ended; embecta. Consultant; Current; General Medicines Inc. Other - Consultant and clinical trial support; Current; GentiBio. Consultant; Ended; Insulet Corporation. Consultant; Current; Kayothera. Other - Consultant and stock options; Current; Metsera. Other - Expert witness; Ended; Medtronic. Other - Consultant and investigator; Current; Novo Nordisk. Consultant; Current; Recordati S.p.A, Sparrow Pharmaceuticals. Consultant; Ended; Tandem Diabetes Care, Inc.. Consultant; Current; Vertex Pharmaceuticals Incorporated, vTv Therapeutics, Zealand Pharma A/S. E.A. Christofides: Consultant; Current; Abbott. Research Support; Current; Abbott Diabetes, Amgen Inc.. Speaker's Bureau; Current; Ascendis Pharma A/S, Chiesi USA, Inc., Eli Lilly and Company. Research Support; Current; Eli Lilly and Company. Advisory Panel; Current; Madrigal Pharmaceuticals, Inc.. Research Support; Current; Novo Nordisk A/S. Speaker's Bureau; Current; Recordati S.p.A, Xeris Pharmaceuticals, Inc.. Advisory Panel; Current; Xeris Pharmaceuticals, Inc.. Research Support; Current; Corcept Therapeutics. Speaker's Bureau; Current; Corcept Therapeutics. R.A. DeFronzo: Advisory Panel; Ended; AstraZeneca. Research Support; Current; AstraZeneca. Advisory Panel; Current; Novo Nordisk. Research Support; Current; Eli Lilly and Company. Advisory Panel; Current; Corcept Therapeutics. Speaker's Bureau; Current; Corcept Therapeutics. Consultant; Current; Alnylam Pharmaceuticals, Inc.. Advisory Panel; Current; Regeneron Pharmaceuticals Inc., Aardvark. B. Eilerman: Speaker's Bureau; Current; Corcept Therapeutics, Lilly, Novo Nordisk, Abbott, Dexcom, Inc.. Advisory Panel; Current; Recordati S.p.A. V. Fonseca: Consultant; Current; Abbott Diabetes. Stock/Shareholder; Current; BRAVO4HEALTH, LLC. Consultant; Ended; Bayer AG. Consultant; Current; Eli Lilly and Company, Corcept Therapeutics, Regeneron Pharmaceuticals Inc., Boehringer Ingelheim International GmbH. Stock/Shareholder; Current; Vertex Pharmaceuticals Incorporated. Y. Handelsman: Consultant; Current; Amgen Inc.. Advisory Panel; Current; AstraZeneca. Research Support; Current; AstraZeneca. Advisory Panel; Ended; Bayer AG. Advisory Panel; Current; Corcept Therapeutics. Research Support; Current; Corcept Therapeutics. Advisory Panel; Ended; Boehringer Ingelheim International GmbH. Research Support; Current; Ionis Pharmaceuticals. Advisory Panel; Current; Merck Sharp & Dohme Corp.. Research Support; Current; Merck Sharp & Dohme Corp.. Y. Kang: None. J.C. Parker: Speaker's Bureau; Current; Corcept Therapeutics. Research Support; Current; Corcept Therapeutics. Speaker's Bureau; Current; Novo Nordisk, Insulet Corporation. A. Philis-Tsimikas: Research Support; Current; Dexcom, Inc., Lilly, Novo Nordisk. Advisory Panel; Current; Novo Nordisk, Gan & Lee Pharmaceuticals. Research Support; Current; Sanofi-Aventis U.S. R. Pratley: Consultant; Current; Lilly USA LLC. Research Support; Current; National Institutes of Health, Novo Nordisk. Speaker's Bureau; Current; Novo Nordisk. Other - Consulting: Thru 12/31/2023 payment directed to Dr. Pratley's employer; as of 1/1/2024 payment directed to Dr. Pratley personally.; Current; Novo Nordisk. Consultant; Current; Pfizer Inc., Recordati Rare Diseases Inc., Regeneron Pharmaceuticals Inc., Response Pharmaceuticals, Rona Therapeutics Ltd. Research Support; Current; Sanofi. Consultant; Current; Scholar Rock Inc.. Other - Consulting: Thru 12/31/2023 payment directed to Dr. Pratley's employer; as of 1/1/2024 payment directed to Dr. Pratley personally.; Current; Sun Pharmaceutical Industries Ltd.. Consultant; Current; Third Rock Ventures, Verdiva Bio Dev Limited. Research Support; Current; AstraZeneca AB, Boehringer Ingelheim International GmbH, Abbott Laboratories. Consultant; Current; Abbott Laboratories, AbbVie Inc.. Other - Consulting; stock options; Current; Altanine, Inc.. Consultant; Current; Amgen Inc., AstraZeneca Pharmaceuticals LP. Other - Consulting: Thru 12/31/2023 payment directed to Dr. Pratley's employer; as of 1/1/2024 payment directed to Dr. Pratley personally.; Current; Bayer AG, Bayer HealthCare Pharmaceuticals Inc.. Research Support; Current; Biomea Fusion. Consultant; Current; Boehringer Ingelheim Pharmaceuticals Inc., Carmot Therapeutics, Inc., Corcept Therapeutics. Research Support; Current; Dompé, Eli Lilly and Company. Other - Consulting: Thru 12/31/2023 payment directed to Dr. Pratley's employer; as of 1/1/2024 payment directed to Dr. Pratley personally.; Current; Eli Lilly and Company. Research Support; Current; Endogenex Inc.. Other - Consulting: Thru 12/31/2023 payment directed to Dr. Pratley's employer; as of 1/1/2024 payment directed to Dr. Pratley personally.; Current; Endogenex Inc.. Consultant; Current; F. Hoffmann-La Roche Ltd.. Research Support; Current; Fractyl Health, Inc.. Other - Consulting: Thru 12/31/2023 payment directed to Dr. Pratley's employer; as of 1/1/2024 payment directed to Dr. Pratley personally.; Ended; Gasherbrum Bio Inc., Genprex. Consultant; Current; Hanmi Pharm. Co., Ltd.. Other - Consulting: Thru 12/31/2023 payment directed to Dr. Pratley's employer; as of 1/1/2024 payment directed to Dr. Pratley personally.; Ended; Intas Pharmaceuticals Ltd.. Research Support; Current; Lexicon Pharmaceuticals, Inc.. Consultant; Current; Lexicon Pharmaceuticals, Inc.. Speaker's Bureau; Current; Lilly USA LLC. J. Rosenstock: Advisory Panel; Ended; Amgen Inc.. Research Support; Current; Amgen Inc., AstraZeneca. Advisory Panel; Ended; Biomea Fusion, Corcept Therapeutics, Eli Lilly and Company. Research Support; Ended; Eli Lilly and Company. Advisory Panel; Ended; Gan & Lee Pharmaceuticals, Hanmi Pharm. Co., Ltd., Boehringer Ingelheim International GmbH. Research Support; Ended; Boehringer Ingelheim International GmbH. Advisory Panel; Ended; Novo Nordisk. Research Support; Ended; Novo Nordisk, Pfizer Inc.. Advisory Panel; Ended; Regeneron Pharmaceuticals Inc.. Research Support; Ended; Regeneron Pharmaceuticals Inc.. Advisory Panel; Ended; Regor. Research Support; Ended; Regor. Advisory Panel; Ended; Roche Pharmaceuticals. Advisory Panel; Current; Sanofi. Research Support; Current; Sanofi. Advisory Panel; Ended; Structure Therapeutics, Terns. M. Shanik: Speaker's Bureau; Current; Abbott Diabetes, Boehringer Ingelheim International GmbH, Lilly Diabetes, Bayer AG. Research Support; Current; Corcept Therapeutics. Speaker's Bureau; Current; Xeris Pharmaceuticals, Inc., Amgen Inc., Madrigal Pharmaceuticals, Inc., Ascendis Pharma A/S. G. Umpierrez: Research Support; Current; Abbott, Dexcom, Inc., Bayer AG. Advisory Panel; Ended; Sanofi-Aventis U.S., Dexcom, Inc.. Other - Education grant; Current; Lilly Diabetes, Abbott Diabetes. Advisory Panel; Current; Glycare, Glucotrack. Research Support; Current; Corcept Therapeutics. A.L. Hand: Employee; Current; Corcept Therapeutics. T.K. Schlafly: Employee; Current; Corcept Therapeutics. Stock/Shareholder; Current; Corcept Therapeutics. D.F. Einhorn: Employee; Current; Corcept Therapeutics.

Lance Sloan

Texas Institute for Kidney and Endocrine Disorders

Appearances